Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 564 (LINC00564) is a human long non-coding RNA gene that lies in intergenic regions, meaning it does not overlap with known protein-coding genes. As with other long intergenic non-coding RNAs (lincRNAs), its RNA transcript is over 200 nucleotides long and is presumed to be involved in the regulation of gene expression at various levels, including epigenetic, transcriptional, or post-transcriptional processes. However, no published functional studies currently detail the specific biological role, mechanisms, or disease associations of LINC00564 itself in humans, and it is not classified as a therapeutic target, receptor, enzyme, transporter, or similar entity. As such, it serves as an example of the many lincRNAs of which the function remains to be elucidated, even though the broader class of lincRNAs is increasingly implicated in processes such as cell proliferation, apoptosis, and cancer biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 564 (LINC00564).